Nalaganje...
Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice
BACKGROUND: Induction of cell apoptosis and regulation of cell cycle are very attractive for treatments of tumors including ovarian carcinoma. Flavopiridol is a potent small molecular cyclin-dependent kinase(cdk) inhibitor, but its antitumor efficacy is not satisfied yet. Caspase-3 play a major role...
Shranjeno v:
izdano v: | J Ovarian Res |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BioMed Central
2014
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4302516/ https://ncbi.nlm.nih.gov/pubmed/25528169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-014-0121-3 |
Oznake: |
Označite
Brez oznak, prvi označite!
|